Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC101927204 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
C5orf56 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTN3A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IFITM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RCAN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MT1X - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF213 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF618 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTN3A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDM5A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FLT3LG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GBP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNFX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RTP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APOL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101060835 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MT2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on